Find Aminolevulinic Acid HCl manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

API REF. PRICE (USD/KG)

MARKET PLACE

FINISHED DOSAGE FORMULATIONS

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Annual Reports

NA

26 RELATED EXCIPIENT COMPANIES

56EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 5451-09-2, Aminolevulinic acid hydrochloride, Levulan, 5-amino-4-oxopentanoic acid hydrochloride, Levulan kerastick, 5-aminolevulinic acid hcl
Molecular Formula
C5H10ClNO3
Molecular Weight
167.59  g/mol
InChI Key
ZLHFONARZHCSET-UHFFFAOYSA-N
FDA UNII
V35KBM8JGR

Aminolevulinic Acid HCl
A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
1 2D Structure

Aminolevulinic Acid HCl

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-amino-4-oxopentanoic acid;hydrochloride
2.1.2 InChI
InChI=1S/C5H9NO3.ClH/c6-3-4(7)1-2-5(8)9;/h1-3,6H2,(H,8,9);1H
2.1.3 InChI Key
ZLHFONARZHCSET-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C(CC(=O)O)C(=O)CN.Cl
2.2 Other Identifiers
2.2.1 UNII
V35KBM8JGR
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5 Aminolaevulinate

2. 5 Aminolevulinate

3. 5-aminolaevulinate

4. 5-aminolevulinate

5. Acid Hydrochloride, Aminolevulinic

6. Acid, Aminolevulinic

7. Acid, Delta-aminolevulinic

8. Aminolevulinic Acid

9. Aminolevulinic Acid Hydrochloride

10. Delta Aminolevulinic Acid

11. Delta-aminolevulinic Acid

12. Hydrochloride, Aminolevulinic Acid

13. Levulan

2.3.2 Depositor-Supplied Synonyms

1. 5451-09-2

2. Aminolevulinic Acid Hydrochloride

3. Levulan

4. 5-amino-4-oxopentanoic Acid Hydrochloride

5. Levulan Kerastick

6. 5-aminolevulinic Acid Hcl

7. Gliolan

8. Aminolevulinic Acid Hcl

9. Ameluz

10. Delta-aminolevulinic Acid Hydrochloride

11. Mfcd00012869

12. Alaglio

13. Gleolan

14. Alabel

15. Pentanoic Acid, 5-amino-4-oxo-, Hydrochloride

16. 5-aminolevulinic Acid, Hcl

17. 5-aminolevulinic Acid (hydrochloride)

18. 5-aminolevulinate Hydrochloride

19. 5-ala

20. Nsc-18509

21. V35kbm8jgr

22. 5-aminolevulinic Acid Hydrochloride Salt

23. .delta.-aminolevulinic Acid Hydrochloride

24. 5-amino-4-oxopentanoic Acid;hydrochloride

25. Npc-07

26. (4-carboxy-2-oxobutyl)azanium;chloride

27. 5-amino-4-oxopentanoic Acid Hcl

28. Aminolevulinic Acid Hydrochloride [usan]

29. Ncgc00095111-01

30. Dsstox_cid_25914

31. Dsstox_rid_81222

32. Dsstox_gsid_45914

33. 5-amino-4-oxopentanoic Acid Hydrochloride;5-amino-4-oxopentanoic Acid

34. Cas-5451-09-2

35. 5-amino-levulinic Acid Hydrochloride

36. 5-aminolevulinic Acid Hydrochloride, >=97.0% (at)

37. Alacare

38. Ala Hydrochloride

39. Einecs 226-679-5

40. Gleolan (tn)

41. Levulan (tn)

42. Ameluz (tn)

43. Nsc 18509

44. Ala Hcl

45. Ala-pdt

46. Levulinic Acid, 5-amino-, Hydrochloride

47. Unii-v35kbm8jgr

48. 5-amino-3-oxopentanoic Acid (hydrochloride)

49. 5-aminolevulinic Acid.hcl

50. Ala;5-ala

51. Pentanoic Acid, Hydrochloride

52. 5-amino-4-keto-valeric Acid

53. Schembl192308

54. Spectrum1504184

55. Chembl1200582

56. Dtxsid5045914

57. Chebi:132969

58. Hms1922f13

59. Pd-p-506-a

60. Pharmakon1600-01504184

61. 5 Ala Hcl (trivial Name)

62. Act05562

63. Bcp02161

64. Hy-n0305

65. Nsc18509

66. 5-amino Levulinic Acid Hydrochloride

67. Tox21_111426

68. Ccg-39079

69. Nsc758687

70. Akos015904495

71. Aminolevulinic Acid Hcl [inci]

72. Tox21_111426_1

73. Ac-4252

74. Bcp9000174

75. Gs-3020

76. Nsc-758687

77. 4-carboxy-2-oxobutan-1-aminium Chloride

78. 5-aminolevulinic Acid Hydrochloride, Gmp

79. Ncgc00095111-02

80. Ncgc00095111-03

81. Ncgc00178086-03

82. 5451-09-2 (hcl)

83. Sy017972

84. Db-005367

85. 5-aminolevulinic Acid Hydrochloride, >=98%

86. A0325

87. Am20100341

88. S2553

89. Sw218068-2

90. Aminolevulinic Acid Hydrochloride (jan/usan)

91. A-6100

92. A-6102

93. A-6103

94. A-6105

95. Aminolevulinic Acid Hydrochloride [jan]

96. D02908

97. Aminolevulinic Acid Hydrochloride [mart.]

98. 451a092

99. Aminolevulinic Acid Hydrochloride [usp-rs]

100. Aminolevulinic Acid Hydrochloride [who-dd]

101. .delta.-aminolevulinic Acid Hydrochloride [mi]

102. 5-aminolevulinic Acid Hydrochloride [ema Epar]

103. Aminolevulinic Acid Hydrochloride [orange Book]

104. Q27291473

105. Aminolevulinic Acid Hydrochloride [usp Monograph]

106. 0c1e43db-1221-4963-bfa4-18d3170000a4

107. 5-aminolevulinic Acid Hydrochloride, Particle Size < 0.25 Mm

108. Aminolevulinic Acid Hydrochloride Component Of Sonala001

109. Aminolevulinic Acid Hydrochloride Component Of Sonala-001

110. 5-aminolevulinic Acid Hydrochloride, Bioreagent, Suitable For Cell Culture, Powder, >=98%

111. Aminolevulinic Acid Hcl; Aminolevulinic Acid Hydrochloride;ala; 5-ala;aminolevulinic Acid

112. Aminolevulinic Acid Hydrochloride, United States Pharmacopeia (usp) Reference Standard

2.4 Create Date
2005-07-19
3 Chemical and Physical Properties
Molecular Weight 167.59 g/mol
Molecular Formula C5H10ClNO3
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count4
Exact Mass167.0349209 g/mol
Monoisotopic Mass167.0349209 g/mol
Topological Polar Surface Area80.4 Ų
Heavy Atom Count10
Formal Charge0
Complexity121
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameLevulan
PubMed HealthAminolevulinic Acid (On the skin)
Drug ClassesPhotosensitizing Agent
Active IngredientAminolevulinic acid hydrochloride
Dosage FormSolution
RouteTopical
Strength20%
Market StatusPrescription
CompanyDusa

2 of 2  
Drug NameLevulan
PubMed HealthAminolevulinic Acid (On the skin)
Drug ClassesPhotosensitizing Agent
Active IngredientAminolevulinic acid hydrochloride
Dosage FormSolution
RouteTopical
Strength20%
Market StatusPrescription
CompanyDusa

4.2 Drug Indication

Treatment of actinic keratosis of mild to moderate severity on the face and scalp (Olsen grade 1 to 2; see section 5. 1) and of field cancer ization in adults.

Treatment of superficial and/or nodular basal cell carcinoma unsuitable for surgical treatment due to possible treatment-related morbidity and/or poor cosmetic outcome in adults.


Gliolan is indicated in adult patients for visualisation of malignant tissue during surgery for malignant glioma (World Health Organization grade III and IV).


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Photosensitizing Agents

Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Optical Imaging Agent [EPC]; Porphyrin Precursor [EPC]; Porphyrinogens [CS]; Fluorescence Contrast Activity [MoA]; Porphyrin Precursor [EPC]
5.3 ATC Code

L01XD04


L01XD04


API SUPPLIERS

read-more
read-more

01

Midas Pharma

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMidas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

Flag Germany
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC KDMF VMF ASMF, CH... arrow-down AUDIT
Midas Pharma

02

Bachem AG

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT
Bachem company banner

03

Heraeus Holding

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SupplySide West 2024
Not Confirmed
arrow

Heraeus Holding

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SupplySide West 2024
Not Confirmed
USDMF arrow-down CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank

04

Nippon Rikagaku Yakuhin

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SupplySide West 2024
Not Confirmed
arrow

Nippon Rikagaku Yakuhin

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SupplySide West 2024
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

05

MEDAC GESELLSCHAFT FUR KLINISCHE S...

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SupplySide West 2024
Not Confirmed
arrow

MEDAC GESELLSCHAFT FUR KLINISCHE S...

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SupplySide West 2024
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

06

Juzen Chemical Corporation

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SupplySide West 2024
Not Confirmed
arrow

Juzen Chemical Corporation

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SupplySide West 2024
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

07

Jiangsu Lianhuan Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SupplySide West 2024
Not Confirmed
arrow

08

Guangzhou Tosun Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SupplySide West 2024
Not Confirmed
arrow

09

Biosynth AG

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SupplySide West 2024
Not Confirmed
arrow

Biosynth AG

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SupplySide West 2024
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Nihon Rikagaku

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SupplySide West 2024
Not Confirmed
arrow

Nihon Rikagaku

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SupplySide West 2024
Not Confirmed
USDMF CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1637087400,"product":"5-AMINOLEVULINIC ACID HYDROCHLORIDE FOR BIOCHEMISTRY 1 PCS X500 MG","address":"GODREJ ONE, 8TH FLR, PIROJSHANAGAR, EASTERN EXPRESS HIGHWAY VIKHROLI-E","city":"MUMBAI","supplier":"MERCK GROUP","supplierCountry":"GERMANY","foreign_port":"NA","customer":"MERCK GROUP","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.001","unit":"KGS","unitRateFc":"6693120","totalValueFC":"90","currency":"INR","unitRateINR":"6700480","date":"17-Nov-2021","totalValueINR":"6700.48","totalValueInUsd":"90","indian_port":"BOMBAY AIR","hs_no":"29225090","bill_no":"6282118","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"GODREJ ONE, 8TH FLR, PIROJSHANAGAR, EASTERN EXPRESS HIGHWAY VIKHROLI-E"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1642012200,"product":"5-AMINOLEVULINIC ACID HYDROCHLORIDE FOR BIOCHEMISTRY 2 PCS X2.5 G","address":"GODREJ ONE, 8TH FLR, PIROJSHANAGAR, EASTERN EXPRESS HIGHWAY VIKHROLI-E","city":"MUMBAI","supplier":"MERCK GROUP","supplierCountry":"GERMANY","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"MERCK GROUP","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"0.006","unit":"KGS","unitRateFc":"5182423.3","totalValueFC":"418","currency":"INR","unitRateINR":"5190196.7","date":"13-Jan-2022","totalValueINR":"31141.18","totalValueInUsd":"418","indian_port":"BOMBAY AIR","hs_no":"29225090","bill_no":"7070026","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"FRANKFURT\/MAIN INT\\'L","supplierAddress":"","customerAddress":"GODREJ ONE, 8TH FLR, PIROJSHANAGAR, EASTERN EXPRESS HIGHWAY VIKHROLI-E"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1645813800,"product":"5-AMINOLEVULINIC ACID HYDROCHLORIDE FOR BIOCHEMISTRY 1 PCS X500 MG","address":"GODREJ ONE, 8TH FLR, PIROJSHANAGAR, EASTERN EXPRESS HIGHWAY VIKHROLI-E","city":"MUMBAI","supplier":"MERCK GROUP","supplierCountry":"GERMANY","foreign_port":"NA","customer":"MERCK GROUP","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.001","unit":"KGS","unitRateFc":"5689150","totalValueFC":"76","currency":"INR","unitRateINR":"5697680","date":"26-Feb-2022","totalValueINR":"5697.68","totalValueInUsd":"76","indian_port":"BOMBAY AIR","hs_no":"29225090","bill_no":"7653649","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"GODREJ ONE, 8TH FLR, PIROJSHANAGAR, EASTERN EXPRESS HIGHWAY VIKHROLI-E"}]
17-Nov-2021
26-Feb-2022
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

Ameluz (5-aminolevulinic acid hydrochloride) is a topical gel that acts as a photosensitizing agent during photodynamic therapy. It is used primarily for the treatmentsuperficial basal cell carcinoma.


Lead Product(s): Aminolevulinic Acid HCl

Therapeutic Area: Oncology Brand Name: Ameluz

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable October 14, 2024

blank

01

Biofrontera

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Biofrontera

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Details : Ameluz (5-aminolevulinic acid hydrochloride) is a topical gel that acts as a photosensitizing agent during photodynamic therapy. It is used primarily for the treatmentsuperficial basal cell carcinoma.

Brand Name : Ameluz

Molecule Type : Small molecule

Upfront Cash : Not Applicable

October 14, 2024

blank

Details:

Ameluz is the only PDT photosensitizer indicated by the FDA for both lesion-directed and field-directed treatment of Actinic Keratosis.


Lead Product(s): Aminolevulinic Acid HCl

Therapeutic Area: Dermatology Brand Name: Ameluz

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable October 07, 2024

blank

02

Biofrontera

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Biofrontera

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Details : Ameluz is the only PDT photosensitizer indicated by the FDA for both lesion-directed and field-directed treatment of Actinic Keratosis.

Brand Name : Ameluz

Molecule Type : Small molecule

Upfront Cash : Not Applicable

October 07, 2024

blank

Details:

The Company intends to fund ongoing activities related to expediting the development and approval of additional indications for Ameluz (aminolevulinic acid hydrochloride) to treat actinic keratoses.


Lead Product(s): Aminolevulinic Acid HCl

Therapeutic Area: Dermatology Brand Name: Ameluz

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Roth Capital Partners

Deal Size: $16.0 million Upfront Cash: Undisclosed

Deal Type: Private Placement January 23, 2024

blank

03

Biofrontera

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Biofrontera

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Details : The Company intends to fund ongoing activities related to expediting the development and approval of additional indications for Ameluz (aminolevulinic acid hydrochloride) to treat actinic keratoses.

Brand Name : Ameluz

Molecule Type : Small molecule

Upfront Cash : Undisclosed

January 23, 2024

blank

Details:

SONALA-001 (aminolevulinic acid) is a porphyrin precursor and optical imaging agent. The mechanism of action of aminolevulinic acid is as a fluorescence contrast activity.


Lead Product(s): Aminolevulinic Acid HCl

Therapeutic Area: Oncology Brand Name: SONALA-001

Study Phase: Phase I/ Phase IIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable March 08, 2023

blank

04

SonALAsense

U.S.A
arrow
World Vaccine Congress
Not Confirmed

SonALAsense

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Details : SONALA-001 (aminolevulinic acid) is a porphyrin precursor and optical imaging agent. The mechanism of action of aminolevulinic acid is as a fluorescence contrast activity.

Brand Name : SONALA-001

Molecule Type : Small molecule

Upfront Cash : Not Applicable

March 08, 2023

blank

Details:

AMELUZ® (aminolevulinic acid hydrochloride) topical gel, 10%, a porphyrin precursor, in combination with photodynamic therapy using BF-RhodoLED® lamp, is indicated for lesion-directed and field-directed treatment of actinic keratoses.


Lead Product(s): Aminolevulinic Acid HCl

Therapeutic Area: Dermatology Brand Name: Ameluz

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable November 21, 2022

blank

05

Biofrontera

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Biofrontera

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Details : AMELUZ® (aminolevulinic acid hydrochloride) topical gel, 10%, a porphyrin precursor, in combination with photodynamic therapy using BF-RhodoLED® lamp, is indicated for lesion-directed and field-directed treatment of actinic keratoses.

Brand Name : Ameluz

Molecule Type : Small molecule

Upfront Cash : Not Applicable

November 21, 2022

blank

Details:

AMELUZ (aminolevulinic acid hydrochloride) topical gel, 10%, a porphyrin precursor, in combination with photodynamic therapy using BF-RhodoLED® lamp, is indicated for the lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate severity.


Lead Product(s): Aminolevulinic Acid HCl

Therapeutic Area: Dermatology Brand Name: Ameluz

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 06, 2022

blank

06

Biofrontera

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Biofrontera

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Details : AMELUZ (aminolevulinic acid hydrochloride) topical gel, 10%, a porphyrin precursor, in combination with photodynamic therapy using BF-RhodoLED® lamp, is indicated for the lesion-directed and field-directed treatment of actinic keratoses of mild-to-moder...

Brand Name : Ameluz

Molecule Type : Small molecule

Upfront Cash : Not Applicable

September 06, 2022

blank

Details:

Ameluz (Aminolevulinic Acid Hydrochloride) is utilized along with photodynamic therapy (PDT) provided by the Company’s proprietary lamp devices to form Ameluz®-PDT.


Lead Product(s): Aminolevulinic Acid HCl

Therapeutic Area: Dermatology Brand Name: Ameluz

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable May 24, 2022

blank

07

Biofrontera

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Biofrontera

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Details : Ameluz (Aminolevulinic Acid Hydrochloride) is utilized along with photodynamic therapy (PDT) provided by the Company’s proprietary lamp devices to form Ameluz®-PDT.

Brand Name : Ameluz

Molecule Type : Small molecule

Upfront Cash : Not Applicable

May 24, 2022

blank

Details:

The new funds will aid to expand the market presence and strategic position. Together with broadening the product label through three clinical trials running in parallel with licensing partner, this will unravel the enormous market potential Ameluz® has long term.


Lead Product(s): Aminolevulinic Acid HCl

Therapeutic Area: Dermatology Brand Name: Ameluz

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Roth Capital Partners

Deal Size: $9.4 million Upfront Cash: Undisclosed

Deal Type: Private Placement May 19, 2022

blank

08

Biofrontera

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Biofrontera

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Details : The new funds will aid to expand the market presence and strategic position. Together with broadening the product label through three clinical trials running in parallel with licensing partner, this will unravel the enormous market potential Ameluz® has...

Brand Name : Ameluz

Molecule Type : Small molecule

Upfront Cash : Undisclosed

May 19, 2022

blank

Details:

AMELUZ (aminolevulinic acid hydrochloride) topical gel, a porphyrin precursor, in combination with photodynamic therapy using BF-RhodoLED® lamp, is indicated for lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate severity on face and scalp.


Lead Product(s): Aminolevulinic Acid HCl

Therapeutic Area: Dermatology Brand Name: Ameluz

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 21, 2022

blank

09

Biofrontera

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Biofrontera

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Details : AMELUZ (aminolevulinic acid hydrochloride) topical gel, a porphyrin precursor, in combination with photodynamic therapy using BF-RhodoLED® lamp, is indicated for lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate sever...

Brand Name : Ameluz

Molecule Type : Small molecule

Upfront Cash : Not Applicable

April 21, 2022

blank

Details:

Ameluz® is Biofrontera’s first FDA-approved flagship prescription drug is used in combination with the RhodoLED® lamp series for the treatment of Actinic Keratoses, and the topical antibiotic drug Xepi®.


Lead Product(s): Aminolevulinic Acid HCl

Therapeutic Area: Dermatology Brand Name: Ameluz

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable March 17, 2022

blank

10

Biofrontera

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Biofrontera

U.S.A
arrow
World Vaccine Congress
Not Confirmed

Details : Ameluz® is Biofrontera’s first FDA-approved flagship prescription drug is used in combination with the RhodoLED® lamp series for the treatment of Actinic Keratoses, and the topical antibiotic drug Xepi®.

Brand Name : Ameluz

Molecule Type : Small molecule

Upfront Cash : Not Applicable

March 17, 2022

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATES SUPPLIERS

read-more
read-more

01

SupplySide West 2024
Not Confirmed
arrow
SupplySide West 2024
Not Confirmed
arrow

CAS Number : 14794-31-1

End Use API : Aminolevulinic Acid HCl

About The Company : Bhushilpa Chemicals was set up in 2001 with a vision to develop, manufacture and market specialty chemicals and drug intermediates through implementation of qu...

blank

02

SupplySide West 2024
Not Confirmed
arrow
SupplySide West 2024
Not Confirmed
arrow

CAS Number : 1490-25-1

End Use API : Aminolevulinic Acid HCl

About The Company : Bhushilpa Chemicals was set up in 2001 with a vision to develop, manufacture and market specialty chemicals and drug intermediates through implementation of qu...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Biofrontera

U.S.A
SupplySide West 2024
Not Confirmed
arrow

Biofrontera

U.S.A
arrow
SupplySide West 2024
Not Confirmed

aminolevulinic acid hydrochloride

Brand Name : Ameluz

Dosage Form : GEL

Dosage Strength : 78 MG / G

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

02

SupplySide West 2024
Not Confirmed
arrow
arrow
SupplySide West 2024
Not Confirmed

AMINOLEVULINIC ACID HYDROCHLORIDE

Brand Name : LEVULAN KERASTICK

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 20%

Packaging : 1.5ML

Approval Date :

Application Number : 2243933

Regulatory Info : Prescription

Registration Country : Canada

blank

03

Galderma

Switzerland
SupplySide West 2024
Not Confirmed
arrow

Galderma

Switzerland
arrow
SupplySide West 2024
Not Confirmed

aminolevulinic acid hydrochloride

Brand Name : Alacare

Dosage Form : MEDICAL PATCH

Dosage Strength : 8 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

04

Gebro Pharma

Austria
SupplySide West 2024
Not Confirmed
arrow

Gebro Pharma

Austria
arrow
SupplySide West 2024
Not Confirmed

Aminolaevulinatis hydrochloridum

Brand Name : Alacare

Dosage Form : Pfl

Dosage Strength : 8mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

05

Gebro Pharma

Austria
SupplySide West 2024
Not Confirmed
arrow

Gebro Pharma

Austria
arrow
SupplySide West 2024
Not Confirmed

Aminolaevulinatis hydrochloridum

Brand Name : Alacare

Dosage Form : Pfl

Dosage Strength : 8mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

06

Louis Widmer

Switzerland
SupplySide West 2024
Not Confirmed
arrow

Louis Widmer

Switzerland
arrow
SupplySide West 2024
Not Confirmed

Acidum aminolevulinicum

Brand Name : Ameluz

Dosage Form : Gel

Dosage Strength : 78mg/g

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

07

SupplySide West 2024
Not Confirmed
arrow
arrow
SupplySide West 2024
Not Confirmed

AMINOLEVULINIC ACID HYDROCHLORIDE

Brand Name : GLEOLAN

Dosage Form : FOR SOLUTION;ORAL

Dosage Strength : 1.5GM/VIAL

Packaging :

Approval Date : 2017-06-06

Application Number : 208630

Regulatory Info : RX

Registration Country : USA

blank

08

SupplySide West 2024
Not Confirmed
arrow
arrow
SupplySide West 2024
Not Confirmed

AMINOLEVULINIC ACID HYDROCHLORIDE

Brand Name : LEVULAN

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 20%

Packaging :

Approval Date : 1999-12-03

Application Number : 20965

Regulatory Info : RX

Registration Country : USA

blank

09

Country
SupplySide West 2024
Not Confirmed
arrow

Country
arrow
SupplySide West 2024
Not Confirmed

aminolevulinic acid hydrochloride

Brand Name : Gliolan

Dosage Form : POWDER FOR ORAL SOLUTION

Dosage Strength : 30 MG / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

10

Country
SupplySide West 2024
Not Confirmed
arrow

Country
arrow
SupplySide West 2024
Not Confirmed

Aminolevulinic Acid

Brand Name : Gliolan

Dosage Form : Powder for potion, resolution

Dosage Strength : 30 mg/ml

Packaging : Hood glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

BIOFRONTERA

U.S.A
Saudi International Expo
Not Confirmed
arrow

BIOFRONTERA

U.S.A
arrow
Saudi International Expo
Not Confirmed

AMINOLEVULINIC ACID HYDROCHLORIDE

Brand Name : AMELUZ

Dosage Form : GEL;TOPICAL

Dosage Strength : 10%

Approval Date : 2016-05-10

Application Number : 208081

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

02

NXDC

U.S.A
Saudi International Expo
Not Confirmed
arrow

NXDC

U.S.A
arrow
Saudi International Expo
Not Confirmed

AMINOLEVULINIC ACID HYDROCHLORIDE

Brand Name : GLEOLAN

Dosage Form : FOR SOLUTION;ORAL

Dosage Strength : 1.5GM/VIAL

Approval Date : 2017-06-06

Application Number : 208630

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

03

Saudi International Expo
Not Confirmed
arrow
arrow
Saudi International Expo
Not Confirmed

AMINOLEVULINIC ACID HYDROCHLORIDE

Brand Name : LEVULAN

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 20%

Approval Date : 1999-12-03

Application Number : 20965

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Solubilizers

read-more
read-more

Topical

read-more
read-more

Parenteral

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Emulsifying Agents

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Rheology Modifiers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Direct Compression

read-more
read-more

Co-Processed Excipients

read-more
read-more

Coating Systems & Additives

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty